Mabapi le kankere / kalafo / lithethefatsi / sebete

Lithethefatsi li Amoheloa Kankere ea Sebete

Leqephe lena le thathamisa lithethefatsi tsa mofetše tse amoheloang ke Tsamaiso ea Lijo le Lithethefatsi (FDA) bakeng sa mofetše oa sebete. Lethathamo lena le kenyelletsa mabitso a tlhaho le mabitso a mabitso. Mabitso a lithethefatsi a hokahana le kakaretso ea tlhaiso-leseling ea lithethefatsi ea Cancer ea NCI. Ho kanna ha ba le lithethefatsi tse sebelisoang kankere ea sebete tse sa thathamisitsoeng mona.

Lithethefatsi li Amoheloa Kankere ea Sebete

Cabometyx (Cabozantinib-S-Malate)

Cabozantinib-S-Malate

Cyramza (Ramucirumab)

Keytruda (Pembrolizumab)

Lenvatinib Mesylate

Lenvima (Lenvatinib Mesylate)

Nexavar (Sorafenib Tosylate)

Nivolumab

Opdivo (Nivolumab)

Pembrolizumab

Ramucirumab

Regorafenib

Sorafenib Tosylate

Stivarga (Regorafenib)